A Cascade‐Targeting System Delivering Polyphenol Into the Mitochondria of M1 Macrophages for Inflammatory Bowel Disease Therapy
Advanced Healthcare Materials · 2026-02 · 15 (6)
DOI: 10.1002/adhm.202503377 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 27.10.2025. Verfasst von Xin Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Macrophages, Mitochondria, Polyphenols. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Double First-Rate construction plan of China Pharmaceutical University.
Abstract (Originalsprache)
Precise intervention targeting the mitochondria of macrophages represents a promising therapeutic strategy to address the challenges of limited clinical efficacy and high risk of adverse reactions in current pharmacological treatments for inflammatory bowel disease (IBD). Herein, a cascade‐targeting system, namely HP‐mExo/TP@Qu (HET@Qu), is rationally designed for the precise delivery of quercetin (Qu, a natural polyphenol with antioxidant and anti‐inflammatory properties) to the mitochondria of intestinal M1 macrophages. HET@Qu comprises a CD44‐targeting shell (HP‐mExo) and a mitochondria‐targeting core (TP@Qu), which sequentially enable targeted delivery at the cellular and subcellular levels. Notably, the development of tannic acid (TA)‐based mitochondria‐targeting micelles (TP@Qu) reported herein demonstrates the feasibility of leveraging natural products for the construction of functional vectors and expands the toolkit of mitochondria‐targeted delivery. In animal experiments, HET@Qu demonstrates significant therapeutic efficacy by attenuating inflammatory cascades, restoring the impaired intestinal epithelial barrier, promoting the M2 polarization of macrophages, and rebalancing gut microbiota homeostasis. Collectively, by integrating a CD44‐targeting shell and a mitochondria‐targeting core, HET@Qu overcomes the last mile challenge of Qu delivery by escorting Qu to critical sites, thereby providing a new choice for the precise treatment of IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China.
- Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 211198, China.
ORCID-Profile: Dawei Deng
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- Double First-Rate construction plan of China Pharmaceutical University
- Jiangsu Provincial Natural Science Fund for Distinguished Young Scholars
- National Key Research and Development Program of China
Zitieren
APA
Liu, X., Wang, X., Yue, Z., Miao, Y., Cao, Y., Zhao, X., & Deng, D. (2026). A Cascade‐Targeting System Delivering Polyphenol Into the Mitochondria of M1 Macrophages for Inflammatory Bowel Disease Therapy. Advanced Healthcare Materials, 15(6). https://doi.org/10.1002/adhm.202503377
Vancouver
Liu X, Wang X, Yue Z, Miao Y, Cao Y, Zhao X, et al. A Cascade‐Targeting System Delivering Polyphenol Into the Mitochondria of M1 Macrophages for Inflammatory Bowel Disease Therapy. Advanced Healthcare Materials. 2026;15(6). doi:10.1002/adhm.202503377
BibTeX
@article{Liu2026,
author = {Liu, Xin and Wang, Xin and Yue, Zongxin and Miao, Yuhang and Cao, Yuqi and Zhao, Xiaomin and Deng, Dawei},
title = {A Cascade‐Targeting System Delivering Polyphenol Into the Mitochondria of M1 Macrophages for Inflammatory Bowel Disease Therapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {6},
doi = {10.1002/adhm.202503377}
}
EUVIMED